Comparison of existing methods of low-density lipoprotein cholesterol estimation in patients with type 2 diabetes mellitus
نویسندگان
چکیده
Introduction: Elevated low-density lipoprotein cholesterol (LDL-C) is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). Direct LDL-C measurement not widely performed. routinely calculated using the Friedewald equation (FLDL), which inaccurate at high triglyceride (TG) or low levels. We aimed to compare this routine method with other estimation methods in patients type 2 diabetes mellitus (T2DM), who typically have elevated TG levels and ASCVD risk. Method: performed a retrospective cohort study on T2DM from multi-institutional registry Singapore 2013 2020. values estimated by equations: FLDL, Martin/Hopkins (MLDL) Sampson (SLDL) were compared measures of agreement correlation. Subgroup analysis comparing directly measured (DLDL) was conducted single institution. Estimated considered discordant if <1.8mmol/L index ≥1.8mmol/L comparator. Results: A total 154,877 included final analysis, 11,475 subgroup analysis. All 3 equations demonstrated strong overall correlation goodness-of-fit. Discordance 4.21% FLDL-SLDL 6.55% FLDL-MLDL. In discordance 21.57% DLDL-FLDL, 17.31% DLDL-SLDL 14.44% DLDL-MLDL. rates increased >4.5mmol/L. Conclusion: correlations between newer estimation, DLDL. At higher concentrations, no well. The had least DLDL, may minimise misclassification FLDL SLDL.
منابع مشابه
Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia, insulin resistance, and/or progressive loss of β-cell function. T2DM patients are at increased risk of micro- and macrovascular disease, and are often considered as representing an atherosclerotic coronary heart disease (CHD) risk equivalent. Interventions directed at glucose and lipid level control in T2DM patients may reduce m...
متن کاملIndependent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus.
BACKGROUND The risk association between low-density lipoprotein (LDL) cholesterol and cancer remains controversial and largely unexplored for people not receiving statin therapy. METHODS We examined the risk association between LDL cholesterol and cancer among patients with type 2 diabetes mellitus who were free of cancer at enrolment and whose statin use was known. We considered a variety of...
متن کاملAtorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.
BACKGROUND AND OBJECTIVES Patients undergoing maintenance hemodialysis are at high cardiovascular risk. Lowering LDL-cholesterol with statins reduces the incidence rate of cardiovascular events in patients with chronic kidney disease. In contrast, two randomized, prospective, placebo-controlled trials have been completed in hemodialysis patients that showed no significant effects of statins on ...
متن کاملHigh -density lipoprotein cholesterol as a predictor for diabetes mellitus
Background: Diabetes is a prevalent chronic disease around the world. To evaluate risk of diabetes comprehensively, we developed a score model for the risk prediction with HDL-C as a protective factor. Methods: We extracted physical examination data of 2728 individuals. The data contain 18 demographic and clinical variables. To identify the statistical significant feature variables, the backwa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals Academy of Medicine Singapore
سال: 2023
ISSN: ['0304-4602']
DOI: https://doi.org/10.47102/annals-acadmedsg.2022477